Cornerstone Therapeutics' David Price Named 2009 Chief Financial Officer of the Year by the Triangle Busine... ( CARY N.C. July 20 /- Corn...)

Cornerstone Therapeutics' David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business Journal

Date:7/20/2009

CARY, N.C., July 20 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing products primarily for the respiratory and related markets, announced today that David Price, Executive Vice President, Finance, and Chief Financial Officer, has been named Triangle Business Journal's CFO of the Year in the Small Public Business category. Award recipients were recognized at the inaugural Triangle Business Journal's CFO of the Year Awards Luncheon held in Cary on July 14, 2009.

"David is very deserving of this award and we congratulate him on this honor," said Cornerstone's President and CEO, Craig Collard. "Cornerstone has achieved tremendous growth in recent months and David has played a critical role in shaping the direction of the Company. He has displayed a level of commitment and financial leadership unmatched by most."

Mr. Price joined Cornerstone Therapeutics as Executive Vice President, Finance, and Chief Financial Officer, in September 2008, just prior to the completion of the reverse merger between Critical Therapeutics, Inc. and Cornerstone BioPharma, Inc., a transaction he helped facilitate as managing director at Jefferies & Company, Inc. In addition, Mr. Price was instrumental in finalizing Cornerstone's recently announced agreement with Chiesi Farmaceutici, SpA, a leading European pharmaceutical company headquartered in Parma, Italy, that resulted in a $70 million transaction and Cornerstone's receipt of an exclusive 10-year license for the U.S. commercial rights to Curosurf(R), the world leading treatment approved by the U.S. Food and Drug Administration for Respiratory Distress Syndrome in premature infants.

Mr. Price has more than 25 years of international experience working for leading accounting and investment firms, including Jefferies
'/>"/>

SOURCE Cornerstone Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:5/18/2013)... (PRWEB) May 18, 2013 John Ravera, D.D.S., ... the addition of a new member to his dental team, ... worked in the field for over 10 years. She received ... honors, and was elected a member of Sigma Pi Alpha, ... profession. Marino enjoys working with patients of all ages, helping ...

(Date:5/18/2013)... CA (PRWEB) May 18, 2013 ... latest update to consumers about transvaginal mesh ... federal court Resource4thePeople reports that plaintiffs have ... to court documents. , The rulings came ... District Court in the Southern District of ...

(Date:5/18/2013)... 2013 Creation's Gold has released its ... which features unmatched potency and purity that serves to ... up to provide the very best quality products to ... their wellness goals. The goal is to provide people ... lives. We started by supplying only the best premium ...

(Date:5/17/2013)... NEW YORK, May 18, 2013. Chronic trauma can inflict ... anxiety. Previous imaging studies of people with post-traumatic stress ... can over-or under-react in response to stressful tasks, such ... photo of a threatening face. Now, researchers at NYU ... what happens in the brains of combat veterans with ...

(Date:5/17/2013)... Daily Gossip announced on Monday that their reporters ... Program Yourself Thin regime, Jim Katsoulis. , ... the end of the month in order to teach readers ... and lead a healthy lifestyle, free of food cravings and ... is available for only $97 and it comes with six ...

Breaking Medicine News(10 mins):Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2 Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 2 Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 3 Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 4 Health News:Creation's Gold Launches Potent Garcinia Cambogia Supplement for Weight Loss 2 Health News:For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests 2 Health News:Program Yourself Thin Review and Secrets Revealed By Daily Gossip Magazine 2

[0] Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team [0] 2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents [0] Creation's Gold Launches Potent Garcinia Cambogia Supplement for Weight Loss [0] For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests [0] Program Yourself Thin Review and Secrets Revealed By Daily Gossip Magazine

... KENILWORTH, N.J., Sept. 1 Schering-Plough Corporation (NYSE: ... 12-hour allergy medicine found in the allergy aisle. New CLARITIN 12-Hour ... indoor and outdoor allergy symptoms. The product is available for ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090901/NY68186 ) , ...

... , , , ... workers in today,s economy add additional stress to already overworked employees, ... National Safety Council estimates that employers pay almost $1 billion per ... indirect costs related to workers, compensation. , , ...

... September 2009: The REVISE Study (Reveal in the Investigation of ... in the United Kingdom, previously thought to be suffering from ... fact had symptoms as a result of an abnormal pattern ... REVISE is the first study to show that, ...

... VidaGas propane energy company secures $1.4M investment from ... Sept. 1 VillageReach, the Seattle-based social enterprise that increases ... Foundation for Community Development (FDC), a Mozambique non profit that ... Oasis Fund, a European commercial investment fund specializing in social ...

... ... a Complete Electronic System to ,Improve Patient Care , ... Atlanta, GA (Vocus) September 1, 2009 -- Thousands ... health records. While this has made improvements in patient care, an electronic health records ...

... BUENOS AIRES, Argentina, Sept. 1 Frost & ... 2009 Customer Value Leadership Award in the Latin American computed ... continuously add value to new and existing healthcare providers, positioning ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) , ...

Cached Medicine News:Health News:New Non-Drowsy CLARITIN(R) 12-Hour Gets Allergy Sufferers Through Their Busy Day 2 Health News:New Non-Drowsy CLARITIN(R) 12-Hour Gets Allergy Sufferers Through Their Busy Day 3 Health News:Workers' Compensation Networks Evolve to Meet Changing Needs of Today's Market 2 Health News:Workers' Compensation Networks Evolve to Meet Changing Needs of Today's Market 3 Health News:Syncope and implantable loop recorders: Good value for money? 2 Health News:Syncope and implantable loop recorders: Good value for money? 3 Health News:VillageReach, Foundation for Community Development and Oasis Fund Announce Strategic Investment in Mozambique Social Business 2 Health News:VillageReach, Foundation for Community Development and Oasis Fund Announce Strategic Investment in Mozambique Social Business 3 Health News:VillageReach, Foundation for Community Development and Oasis Fund Announce Strategic Investment in Mozambique Social Business 4 Health News:Electronic Information Exchange Is Critical to Closing the Gap in Health Care Reform 2 Health News:Electronic Information Exchange Is Critical to Closing the Gap in Health Care Reform 3 Health News:Electronic Information Exchange Is Critical to Closing the Gap in Health Care Reform 4 Health News:Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award 2 Health News:Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award 3 Health News:Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award 4

New Non-Drowsy CLARITIN(R) 12-Hour Gets Allergy Sufferers Through Their Busy Day Workers' Compensation Networks Evolve to Meet Changing Needs of Today's Market Syncope and implantable loop recorders: Good value for money?VillageReach, Foundation for Community Development and Oasis Fund Announce Strategic Investment in Mozambique Social Business Electronic Information Exchange Is Critical to Closing the Gap in Health Care Reform Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award

(Date:5/18/2013)... 2013 Faruqi & Faruqi, LLP, a ... securities fraud at AVEO Pharmaceuticals, Inc. ("AVEO" or ... http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) The investigation focuses ... federal securities laws by issuing materially false and/or ... trials for Tivopath (tivozanib) (titled "TIVO-1"). Specifically, the ...

(Date:5/17/2013)... , May 17, 2013 Sorrento Therapeutics, Inc. ... Fast-Track Advanced Technology Small Business Technology Transfer Research ... Allergy and Infectious Diseases (NIAID), a division of ... development of novel human antibody therapeutics to combat ... or Staph) infections, including methicillin-resistant S. aureus ...

(Date:5/17/2013)... 2013 Sony Biotechnology Inc. ("Sony") today announced the launch ... 130um sorting chip. Sony will also be exhibiting its newly ... Cell Sorter, the EC800 flow cytometer, and new SP6800 Spectral ... which will be held at the San Diego ... , from May 20 - 22. ...

Breaking Medicine Technology:Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2 Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2 Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3 Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4 Sony Delivers New Technology for Science to CYTO 2013 2

[0] Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm [0] Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases [0] Sony Delivers New Technology for Science to CYTO 2013

... & LUND, Sweden--(BUSINESS WIRE)--May 1, 2007 - ... today,announced that data from a 36-week, randomized, ... oral 0.6 mg,dose of laquinimod given daily ... by 38 percent in RRMS,patients and was ...

... pivotal phase III study in women with recurrent ... 2007,/PRNewswire-FirstCall/ -- A new study further supports the ... being,studied for the treatment of ovarian cancer. The ... protein, which triggers,a series of events that selectively ...

Cached Medicine Technology:Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 2 Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 3 Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 4 Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 5 Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 6 New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 2 New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 3 New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 4 New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 5

Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS)New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death

... Surgical Markers allows the surgeon ... with a scrub-resistant, gentian violet ... are provided sterile, with a ... in peel pouches. Micro tip ...

... violet ink stands up ... scale ruler printed on ... quick measuring. Flexible, smudge-proof ... inch and metric scales. ...

Broad tip, gentian violet, sterile, disposable...

Double-ended, one end sharp, other end blunt, 7 1/2", double-ended, 5 mm wide....

Medicine Products:

TLS Surgical Markers Surgiscribe Surgical Marking Pens Marking Pen Freer Periosteal Elevator